In Brief: Pharmacia's Zinecard
Executive Summary
Pharmacia's Zinecard: Price to wholesalers is $215 for a 500 mg single-use vial of the cardioprotective agent and $107.50 for a 250 mg single-use vial. Zinecard (dexrazoxane), approved in May, became available during the week of June 19. Pharmacia's low molecular weight heparin product Fragmin (dalteparin), approved at the end of last year, is not yet available. Reportedly it has been held up by discussions with FDA over promotional labeling issues...
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth